AtriCure (ATRC) Amortizatization of Intangibles (2010 - 2024)
AtriCure (ATRC) posted quarterly Amortizatization of Intangibles of -$107000.0 for Q1 2024, up 36.69% year-over-year from -$78281.4 in Q2 2023, and up 37.43% quarter-over-quarter from -$171000.0 in Q4 2023.
AtriCure (ATRC) Amortizatization of Intangibles (2010 - 2024) Analysis & Trends
AtriCure (ATRC) has reported Amortizatization of Intangibles for 15 consecutive years, with -$107000.0 the latest figure, recorded in Q1 2024.
- In Q1 2024, Amortizatization of Intangibles rose 36.69% year-over-year to -$107000.0; the TTM figure through Dec 2024 stood at -$107000.0 (up 83.07% YoY), while the FY2024 annual figure was -$107000.0, up 83.07% from the prior year.
- Amortizatization of Intangibles grew to -$107000.0 in Q1 2024 per ATRC's latest filing, from -$171000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $3000.0 in Q1 2020 and bottomed at -$651000.0 in Q2 2021.
- Historically, Amortizatization of Intangibles has averaged -$349117.6 across 5 years, with a median of -$289000.0 in 2022.
- Annual changes were most pronounced in 2021 — Amortizatization of Intangibles plunged 18600.0% — and 2023, when it jumped 70.52%.
- AtriCure's Amortizatization of Intangibles stood at -$608000.0 in 2020, then decreased by 4.44% to -$635000.0 in 2021, then jumped by 67.56% to -$206000.0 in 2022, then grew by 16.99% to -$171000.0 in 2023, then jumped by 37.43% to -$107000.0 in 2024.
- Business Quant data shows ATRC's Amortizatization of Intangibles at -$107000.0 in Q1 2024, -$171000.0 in Q4 2023, and -$167000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 38.80 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 10.34 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 500,000.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -107,000.00 |
| Mar 31, 2024 | -107,000.00 |
| Dec 31, 2023 | -171,000.00 |
| Dec 31, 2023 | -171,000.00 |
| Sep 30, 2023 | -167,000.00 |
| Sep 30, 2023 | -167,000.00 |
| Jun 30, 2023 | -125,000.00 |
| Jun 30, 2023 | -125,000.00 |
| Mar 31, 2023 | -169,000.00 |
| Mar 31, 2023 | -169,000.00 |
| Dec 31, 2022 | -206,000.00 |
| Dec 31, 2022 | -206,000.00 |
| Sep 30, 2022 | -289,000.00 |
| Sep 30, 2022 | -289,000.00 |
| Jun 30, 2022 | -424,000.00 |
| Jun 30, 2022 | -424,000.00 |
| Mar 31, 2022 | -559,000.00 |
| Mar 31, 2022 | -559,000.00 |
| Dec 31, 2021 | -635,000.00 |
| Dec 31, 2021 | -635,000.00 |